A Stepwise‐Enhanced Schottky Heterojunction Enables Ultra‐Low‐Dose Radiodynamic Therapy via Matrix Remodeling and Electron–Hole Separation
Advanced Materials · 2026
DOI: 10.1002/adma.202521580 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2026. Verfasst von Chaoyi Lyu und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Advanced Medical Materials and Devices, Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Key Labo…. Hauptthemen laut MEDLINE: Electrons, Radiation-Sensitizing Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: National Science Fund for Distinguished Young Scholars of China, National Natural Science Foundation of China, Tianjin Municipal Science and Technology Commission Grant.
Abstract (Originalsprache)
Radiodynamic therapy (RDT) enhances the production of reactive oxygen species (ROS), thereby reducing clinical radiotherapy doses. Nanoscale metal–organic frameworks (nMOFs) based on high‐Z secondary building units (SBUs) and photosensitizing ligands have been developed to perform RDT. However, the rapid recombination of electron–holes reduces RDT efficiency, and an abundant matrix prevents nMOFs penetration into tumors. In this study, we combine heterojunction engineering with nMOFs‐based RDT for the first time to prepare an Hf‐TCPP/Nb 2 C@PEG Schottky heterojunction (HTNCP). Relying on the Nb 2 C's exceptional electrons absorption and photothermal conversion, HTNCP not only promotes electron–hole separation in Hf‐TCPP, boosting superoxide radical and singlet oxygen production by 2.64‐fold, but also utilizes a mild photothermal effect to degrade the collagen matrix to promote self‐penetration. Through sequential treatment involving irradiation 1064 nm laser and X‐ray, HTNCP can suppress the growth and metastasis of triple‐negative breast cancer tumors in mice using ultra‐low‐dose X‐ray (1 Gy × 5). This novel radiosensitizer displays excellent RDT efficacy and provides a universal sequential treatment strategy of “matrix degradation–RDT killing” for clinical tumor radiotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Advanced Medical Materials and Devices, Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Key Laboratory of Radiopharmacokinetics for Innovative Drugs, Tianjin Institut…
ORCID-Profile: Chaoyi Lyu, Jianfeng Liu
Förderung
- National Science Fund for Distinguished Young Scholars of China
- National Natural Science Foundation of China
- Tianjin Municipal Science and Technology Commission Grant
- Tianjin Natural Science Foundation Project
- CAMS Innovation Fund for Medical Sciences
Zitieren
APA
Lyu, C., Chen, Y., Ning, Y., Guo, Q., Cai, X., Wang, D., Yang, L., & Liu, J. (2026). A Stepwise‐Enhanced Schottky Heterojunction Enables Ultra‐Low‐Dose Radiodynamic Therapy via Matrix Remodeling and Electron–Hole Separation. Advanced Materials. https://doi.org/10.1002/adma.202521580
Vancouver
Lyu C, Chen Y, Ning Y, Guo Q, Cai X, Wang D, et al. A Stepwise‐Enhanced Schottky Heterojunction Enables Ultra‐Low‐Dose Radiodynamic Therapy via Matrix Remodeling and Electron–Hole Separation. Advanced Materials. 2026. doi:10.1002/adma.202521580
BibTeX
@article{Lyu2026,
author = {Lyu, Chaoyi and Chen, Yanbin and Ning, Yingyi and Guo, Qian and Cai, Xiaoyao and Wang, Dianyu and Yang, Lijun and Liu, Jianfeng},
title = {A Stepwise‐Enhanced Schottky Heterojunction Enables Ultra‐Low‐Dose Radiodynamic Therapy via Matrix Remodeling and Electron–Hole Separation},
journal = {Advanced Materials},
year = {2026},
doi = {10.1002/adma.202521580}
}
EUVIMED